EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Epigral's Enterprise Value is ₹60,305 Mil.
Epigral's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₹3,642 Mil. Therefore, Epigral's EV-to-EBIT for today is 16.56.
The historical rank and industry rank for Epigral's EV-to-EBIT or its related term are showing as below:
BOM:543332'
s EV-to-EBIT Range Over the Past 10 Years
Min: 5.86 Med: 11.59 Max: 43.55
Current: 16.56
During the past 7 years, the highest EV-to-EBIT of Epigral was 43.55. The lowest was 5.86. And the median was 11.59.
BOM:543332's EV-to-EBIT is ranked better than 53.13% of 1229
companies
in the Chemicals industry
Industry Median: 17.96
vs BOM:543332: 16.56
The historical data trend for Epigral's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Epigral's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epigral's EV-to-EBIT Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, Epigral's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Epigral's EV-to-EBIT falls into.
Epigral's current Enterprise Value is ₹60,305 Mil.
Epigral's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,642 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epigral (BOM:543332) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Epigral's Enterprise Value for the quarter that ended in Mar. 2024 was ₹54,706 Mil.
Epigral's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,642 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Epigral EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Epigral's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Epigral Ltd Formerly Meghmani Finechem Ltd is a producer of Chlor-Alkali and its Derivatives and specialty chemicals with backward and forward integration facilities. It manufactures Caustic Soda, Caustic Potash, CPVC Resin, Epichlorohydrin, Chlorine, Hydrogen, Chloromethanes, and Hydrogen Peroxide. The company is focused on servicing domestic as well as international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543332 has been successfully added to your 